Top Institutions in Cardiology, Amyloidosis
Leading institutions in cardiology and amyloidosis research conduct large-scale, multicenter clinical trials and long-term extension studies to evaluate novel therapies like acoramidis, leveraging expertise in cardiovascular imaging, biomarker analysis, and patient-centered outcomes.
-
#1
University of Pittsburgh Medical Center
Pittsburgh, PA
Home to the lead author of the referenced study and a leader in transthyretin amyloid cardiomyopathy research, UPMC has extensive experience conducting pivotal clinical trials and long-term follow-up studies on acoramidis.
Key Differentiators
- Cardiology
- Amyloidosis
- Clinical Trials
-
#2
Mayo Clinic
Rochester, MN
Mayo Clinic is internationally recognized for its amyloidosis program and has contributed significantly to the understanding and management of ATTR-CM, including clinical trials and biomarker research.
Key Differentiators
- Cardiology
- Amyloidosis
- Heart Failure
-
#3
Boston University School of Medicine
Boston, MA
Boston University has a strong focus on amyloid cardiomyopathy research, contributing to clinical trials and translational studies on novel therapies including acoramidis.
Key Differentiators
- Cardiology
- Amyloidosis
- Clinical Research
-
#4
Johns Hopkins University
Baltimore, MD
Johns Hopkins has a dedicated amyloidosis program with expertise in clinical and translational research focused on cardiac amyloidosis and emerging therapies.
Key Differentiators
- Cardiology
- Amyloidosis
- Heart Failure
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
